ASGCT News

FilterBy

ASGCT Members Elect Five New Directors from CHOP, UMass, Advanced Therapy Partners, bluebird bio, and Vanderbilt University

Beverly Davidson, Ph.D., Terence R. Flotte, M.D., Maritza McIntyre, Ph.D., Matthew Wilson, M.D., Ph.D., and Philip Gregory, D.Phil. have been elected to the American Society of Gene & Cell Therapy's board of directors by the Society's membership and will join the board at the ASGCT Annual Meeting, April 29-May 2.

ASGCT Members Elect Five New Directors from CHOP, UMass, Advanced Therapy Partners, bluebird bio, and Vanderbilt University
April 09, 2019

Beverly Davidson, Ph.D., Terence R. Flotte, M.D., Maritza McIntyre, Ph.D., Matthew Wilson, M.D., Ph.D., and Philip Gregory, D.Phil. have been elected to the American Society of Gene & Cell Therapy's board of directors by the Society's membership and will join the board at the ASGCT Annual Meeting, April 29-May 2.

ASGCT To Honor Four Ground-Breaking Researchers at 22nd Annual Meeting

ASGCT is proud to introduce the four recipients of the Society's 2019 Outstanding Achievement Award, Outstanding New Investigator Awards, and the Sonia Skarlatos Public Service Award.

Transforming The Face of Science in Australia And Beyond
March 08, 2019

Visibility and role models matter. For International Women’s Day, take time to celebrate the women in STEMM in your organization. Their excellence, ambition, and success should be equally recognized and rewarded.

Inclusivity and Diversity in ASGCT
March 08, 2019

International Women’s Day is held as a focal point in the movement for women’s rights to celebrate women’s achievements throughout history and across nations. While the world still has a long way to go in achieving equal rights for women, at the American Society for Gene and Cell Therapy we have many things to celebrate!

Final FDA Guidance Includes ASGCT Recommendations, Beneficial Revisions
February 19, 2019

Newly finalized FDA guidance documents, originally released for comments in November 2017, clarify policies regarding regenerative medicine and RMAT designation requirements.

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close